Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
SYK

SYK - Stryker Corp Stock Price, Fair Value and News

340.76USD+9.53 (+2.88%)Market Closed

Market Summary

SYK
USD340.76+9.53
Market Closed
2.88%

SYK Stock Price

View Fullscreen

SYK RSI Chart

SYK Valuation

Market Cap

129.6B

Price/Earnings (Trailing)

38.57

Price/Sales (Trailing)

6.18

EV/EBITDA

31.96

Price/Free Cashflow

45.36

SYK Price/Sales (Trailing)

SYK Profitability

Operating Margin

63.80%

EBT Margin

18.69%

Return on Equity

17.53%

Return on Assets

8.53%

Free Cashflow Yield

2.2%

SYK Fundamentals

SYK Revenue

Revenue (TTM)

21.0B

Rev. Growth (Yr)

9.73%

Rev. Growth (Qtr)

-9.84%

SYK Earnings

Earnings (TTM)

3.4B

Earnings Growth (Yr)

33.11%

Earnings Growth (Qtr)

-31.06%

Breaking Down SYK Revenue

Last 7 days

0.4%

Last 30 days

-2.3%

Last 90 days

4.7%

Trailing 12 Months

15.1%

How does SYK drawdown profile look like?

SYK Financial Health

Current Ratio

1.71

Debt/Equity

0.56

Debt/Cashflow

0.32

SYK Investor Care

Dividend Yield

0.9%

Dividend/Share (TTM)

3.05

Shares Dilution (1Y)

0.37%

Diluted EPS (TTM)

8.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202421.0B000
202319.0B19.5B19.9B20.5B
202217.4B17.6B17.9B18.4B
202114.7B16.2B16.7B17.1B
202015.0B14.1B14.2B14.4B
201913.9B14.2B14.5B14.9B
201812.7B13.0B13.3B13.6B
201711.8B12.0B12.1B12.4B
201610.1B10.5B10.9B11.3B
20159.7B9.8B9.8B9.9B
20149.1B9.3B9.5B9.7B
20138.7B8.8B8.9B9.0B
20128.5B8.5B8.5B8.7B
20117.5B7.8B8.1B8.3B
20106.9B7.0B7.2B7.3B
20096.7B6.6B6.6B6.7B
200806.2B6.5B6.7B
20070006.0B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Stryker Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 02, 2024
boehnlein glenn s
acquired
3,062,750
122
25,000
vp, chief financial officer
Jul 02, 2024
boehnlein glenn s
sold (taxes)
-5,774,340
336
-17,160
vp, chief financial officer
May 22, 2024
fletcher robert s
sold
-668,308
332
-2,007
vp, chief legal officer
May 15, 2024
boehnlein glenn s
sold
-3,276,520
327
-10,000
vp, chief financial officer
May 09, 2024
silvernail andrew k
acquired
-
-
653
-
May 09, 2024
mccoy sherilyn s
acquired
-
-
653
-
May 09, 2024
suri rajeev
acquired
-
-
653
-
May 09, 2024
caforio giovanni
acquired
-
-
653
-
May 09, 2024
ruggeri rachel
acquired
-
-
653
-
May 09, 2024
stryker ronda e
acquired
-
-
653
-

1–10 of 50

Which funds bought or sold SYK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 19, 2024
Nvest Financial, LLC
new
-
236,994
236,994
0.15%
Jul 19, 2024
Manitou Investment Management Ltd.
added
17.04
2,482,880
24,498,700
5.48%
Jul 19, 2024
Boston Trust Walden Corp
reduced
-14.36
-28,336,600
124,171,000
0.92%
Jul 19, 2024
Venturi Wealth Management, LLC
added
1,375
573,535
617,554
0.04%
Jul 19, 2024
SMITHBRIDGE ASSET MANAGEMENT INC/DE
added
1.74
-224,761
6,655,290
1.38%
Jul 19, 2024
Apollon Wealth Management, LLC
reduced
-6.67
-376,515
2,965,510
0.09%
Jul 19, 2024
First Pacific Financial
unchanged
-
-846
16,332
-%
Jul 19, 2024
CENTRAL BANK & TRUST CO
added
5.63
18,288
4,224,160
0.59%
Jul 19, 2024
MONECO Advisors, LLC
reduced
-4.38
-58,661
587,365
0.09%
Jul 19, 2024
Sumitomo Mitsui Trust Holdings, Inc.
reduced
-4.82
-39,694,900
378,046,000
0.28%

1–10 of 50

Are Funds Buying or Selling SYK?

Are funds buying SYK calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SYK
No. of Funds

Unveiling Stryker Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.20%
31,149,173
SC 13G/A
Feb 12, 2024
greenleaf trust
4.9%
18,723,395
SC 13G/A
Jan 29, 2024
blackrock inc.
6.6%
24,924,572
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.0%
14,929,245
SC 13G/A
Feb 10, 2023
greenleaf trust
5.3%
19,869,434
SC 13G/A
Feb 09, 2023
vanguard group inc
7.99%
30,246,178
SC 13G/A
Feb 01, 2023
blackrock inc.
6.5%
24,494,206
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
5.5%
21,156,776
SC 13G/A
Feb 11, 2022
greenleaf trust
5.4%
20,452,972
SC 13G/A
Feb 10, 2022
vanguard group inc
7.60%
28,652,681
SC 13G/A

Recent SEC filings of Stryker Corp

View All Filings
Date Filed Form Type Document
Jul 03, 2024
4
Insider Trading
May 24, 2024
SD
SD
May 23, 2024
4
Insider Trading
May 22, 2024
144
Notice of Insider Sale Intent
May 16, 2024
4
Insider Trading
May 15, 2024
144
Notice of Insider Sale Intent
May 14, 2024
8-K
Current Report
May 13, 2024
4
Insider Trading
May 13, 2024
4
Insider Trading
May 13, 2024
4
Insider Trading

Peers (Alternatives to Stryker Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
177.6B
40.3B
-1.87% -8.75%
31.54
4.4
-2.84% -3.00%
66.7B
19.7B
-1.27% -12.39%
50.03
3.38
4.82% -17.56%
18.9B
3.9B
3.77% -24.06%
40.93
4.83
5.72% 46.72%
18.0B
14.9B
4.77% -28.30%
6.8
1.21
2.98% 207.68%
MID-CAP
9.7B
3.5B
-0.49% 22.32%
30.92
2.73
6.16% 35.06%
9.0B
12.4B
3.05% -11.95%
23.22
0.73
-0.93% -18.83%
8.5B
2.6B
2.70% -25.47%
-26.25
3.25
-6.25% -68.58%
5.5B
3.9B
2.69% -35.08%
-57.29
1.39
0.23% 90.80%
3.5B
387.1M
0.41% 33.97%
-217.07
8.93
30.82% 65.57%
2.2B
6.6B
-1.26% -22.56%
11.83
0.33
1.50% -10.09%
SMALL-CAP
1.4B
3.2B
-5.25% -24.25%
-2.04
0.44
7.94% -1695.32%
408.8M
169.3M
6.32% 8.33%
-5.32
2.42
7.49% -244.90%
287.6M
324.0M
27.08% -17.85%
-1.5
0.89
-3.19% -337.41%
46.8M
50.5M
-0.74% -76.96%
-2.05
0.93
14.25% -10.06%
5.7M
3.5M
-39.71% -89.21%
-0.47
1.62
-0.62% -1.48%

Stryker Corp News

Latest updates
Defense World4 hours ago
Simply Wall St11 Jul 202407:00 am
Yahoo Finance09 Jul 202407:00 am
Yahoo Finance27 Jun 202407:00 am

Stryker Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-9.8%5,2435,8154,9094,9964,7785,2024,4794,4934,2754,7014,1604,2943,9534,2623,7372,7643,5884,1313,5873,6503,516
Cost Of Revenue-9.6%1,9102,1121,7511,8151,7621,9661,6971,6671,5411,6561,5181,5221,4441,5451,2761,2161,2571,4281,2571,2701,233
Gross Profit-10.0%3,3333,7033,1583,1813,0163,2362,7822,8262,7343,0452,6422,7722,5092,7172,4611,5482,3312,7032,3302,3802,283
Operating Expenses-3.5%2,3612,4462,2272,2162,2812,4221,9742,0542,2872,2262,0682,0402,0501,9681,6021,5681,6961,7591,7021,7671,755
  S&GA Expenses-5.2%1,8401,9411,7011,7061,7811,7511,4551,5391,7101,7451,6021,5051,5751,5621,2441,2251,3301,3801,2911,2821,403
  R&D Expenses5.1%368350353346339326364351413331306310288255242233254254246246225
EBITDA Margin-4.5%0.21*0.22*0.20*0.20*0.19*0.18*0.19*0.17*0.17*0.17*0.17*0.19*0.16*0.18*0.20*0.19*0.22*0.21*0.20*0.20*-
Income Taxes62.7%13583.0017716187.00198-64.0063.0095.0057.0070.0065.00103159-4.0097.0021111585.0068.00
Earnings Before Taxes-24.7%9231,226869899679761816720386757495662367671780-87.00590936581565480
EBT Margin4.3%0.19*0.18*0.16*0.16*0.16*0.15*0.15*0.13*0.13*0.13*0.13*0.15*0.12*0.14*0.16*0.14*0.18*0.17*0.16*0.16*-
Net Income-31.1%7881,143692738592563816656323662438592302568621-83.00493725466480412
Net Income Margin3.8%0.16*0.15*0.13*0.14*0.14*0.13*0.14*0.12*0.12*0.12*0.11*0.13*0.10*0.11*0.12*0.11*0.14*0.14*0.24*0.25*-
Free Cashflow-97.3%37.001,38390253631581575138684.007948037723691,072760511447536466349-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-1.3%39,40239,91238,04237,40936,83036,88435,98336,03236,13734,63134,14533,69833,45534,33032,28631,48329,44030,16726,65926,35425,937
  Current Assets-5.0%11,89212,51811,04510,15110,15510,2759,3188,8258,72510,0179,4609,0328,9799,70713,54512,80110,73611,0588,5668,1857,888
    Cash Equivalents-21.6%2,3302,9711,8601,4011,6711,8441,4201,0441,4582,9442,5632,2412,2382,9437,0836,5393,9644,3371,9481,7541,674
  Inventory3.8%5,0264,8434,8834,5934,3333,9953,8833,7493,5253,3143,4343,4313,4733,4943,4593,4423,3592,9803,2693,1983,064
  Net PPE1.4%3,2603,2153,1063,0823,0372,9702,7982,8032,7932,8332,7462,7382,7102,7522,5292,5272,6072,5672,4602,3872,297
  Goodwill0.7%15,35115,24315,13815,17214,84914,88014,99315,11515,22812,91812,89312,80212,80312,7789,1289,0749,0259,0698,7048,762114
Liabilities-5.1%20,23021,31920,13720,04819,93520,26819,52020,35821,09119,75419,96719,87819,95321,24619,30018,72916,32517,36014,34414,41114,244
  Current Liabilities-12.2%6,9557,9217,4586,5845,8666,3034,5714,4044,4084,5494,4494,2523,9535,0414,6894,4054,1624,4003,9213,9463,713
  Long Term Debt-0.9%10,80710,90110,38211,14911,85711,85712,75113,37413,88512,47212,62912,73413,05913,23012,00811,8119,40410,2317,8897,9747,950
    LT Debt, Non Current-0.9%10,80710,90110,38211,14911,85711,85712,75113,37413,88512,47212,62912,73413,05913,23012,00811,8119,40410,2317,8897,9747,950
Shareholder's Equity3.1%19,17218,59317,90538.0016,8952,03416,46313,93315,04614,87714,17838.0012,52512,46212,9861,70638.0011,74812,31537.0037.00
  Retained Earnings2.9%17,25416,77115,93315,52615,07214,76514,48613,93313,54013,48013,08112,88112,52512,46212,12911,72512,02411,74811,23810,96710,683
  Additional Paid-In Capital2.6%2,2572,2002,1832,1272,0902,0342,0281,9891,9471,8901,8751,8441,8061,7411,7361,7061,6761,6281,5931,5691,538
Accumulated Depreciation2.2%3,1983,1293,0493,0052,9332,8352,7362,7462,7392,6652,6942,6242,4962,4302,3102,2482,1692,1472,1432,0912,045
Shares Outstanding0.2%380380380379379378378378378377377377376376376375375374374--
Float----109,723---70,965---91,942---63,413---71,863-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-86.6%2041,5281,0506884451,0038895292031,0009338784521,237829620591735629514313
  Share Based Compensation117.5%87.0040.0052.0039.0074.0028.0033.0036.0071.0030.0034.0039.0068.0027.0029.0030.0056.0032.0032.0028.0035.00
Cashflow From Investing-168.4%-408-152-145-533-132-16272.00-152-2,682-314-247-202-96.00-4,352-69.00-117-163-719-186-247-303
Cashflow From Financing-46.2%-418-286-422-405-481-446-543-753993-288-348-676-1,053-1,057-2422,056-7682,363-225-188-1,947
  Dividend Payments6.7%304285285285284263263263262237238237238216216216215193195195195
  Buy Backs---------------------307
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

SYK Income Statement

2024-03-31
CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Net sales$ 5,243$ 4,778
Cost of sales1,9101,762
Gross profit3,3333,016
Research, development and engineering expenses368339
Selling, general and administrative expenses1,8401,781
Amortization of intangible assets153161
Total operating expenses2,3612,281
Operating income972735
Other income (expense), net(49)(56)
Earnings before income taxes923679
Income taxes13587
Net earnings$ 788$ 592
Net earnings per share of common stock:  
Basic (in dollars per share)$ 2.07$ 1.56
Diluted (in dollars per share)$ 2.05$ 1.54
Weighted-average shares outstanding (in millions):  
Basic (in shares)380.4379.0
Effect of dilutive employee stock compensation (in shares)4.74.2
Diluted (in shares)385.1383.2
Cash dividends declared per share of common stock (in dollars per share)$ 0.80$ 0.75

SYK Balance Sheet

2024-03-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 2,330$ 2,971
Marketable securities7782
Accounts receivable, less allowance of $175 ($182 in 2023)3,4733,765
Inventories:  
Materials and supplies1,2321,242
Work in process372330
Finished goods3,4223,271
Total inventories5,0264,843
Prepaid expenses and other current assets986857
Total current assets11,89212,518
Property, plant and equipment:  
Land, buildings and improvements1,6861,692
Machinery and equipment4,7724,652
Total property, plant and equipment6,4586,344
Less allowance for depreciation3,1983,129
Property, plant and equipment, net3,2603,215
Goodwill15,35115,243
Other intangibles, net4,5094,593
Noncurrent deferred income tax assets1,6411,670
Other noncurrent assets2,7492,673
Total assets39,40239,912
Current liabilities  
Accounts payable1,2461,517
Accrued compensation7781,478
Income taxes444391
Dividends payable305304
Accrued expenses and other liabilities2,1242,137
Current maturities of debt2,0582,094
Total current liabilities6,9557,921
Long-term debt, excluding current maturities10,80710,901
Income taxes565567
Other noncurrent liabilities1,9031,930
Total liabilities20,23021,319
Shareholders' equity  
Common stock, $0.10 par value3838
Additional paid-in capital2,2572,200
Retained earnings17,25416,771
Accumulated other comprehensive loss(377)(416)
Total shareholders' equity19,17218,593
Total liabilities and shareholders' equity$ 39,402$ 39,912
SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
 CEO
 WEBSITEstryker.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES51000

Stryker Corp Frequently Asked Questions


What is the ticker symbol for Stryker Corp? What does SYK stand for in stocks?

SYK is the stock ticker symbol of Stryker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Stryker Corp (SYK)?

As of Fri Jul 19 2024, market cap of Stryker Corp is 129.63 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SYK stock?

You can check SYK's fair value in chart for subscribers.

What is the fair value of SYK stock?

You can check SYK's fair value in chart for subscribers. The fair value of Stryker Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Stryker Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SYK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Stryker Corp a good stock to buy?

The fair value guage provides a quick view whether SYK is over valued or under valued. Whether Stryker Corp is cheap or expensive depends on the assumptions which impact Stryker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SYK.

What is Stryker Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 19 2024, SYK's PE ratio (Price to Earnings) is 38.57 and Price to Sales (PS) ratio is 6.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Stryker Corp's stock?

In the past 10 years, Stryker Corp has provided 0.165 (multiply by 100 for percentage) rate of return.